SCHEMBL7830360

SCHEMBL7830360

Oc1cc(F)ccc1N1CCNCC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.50
HTR1A P08908 9/20 0.49
SLC6A2 P23975 3/20 0.49
SLC6A4 P31645 3/20 0.49
HTR7 P34969 4/20 0.49
HTR2A P28223 2/20 0.49
DRD2 P14416 2/20 0.49
DRD3 P35462 2/20 0.49
DRD1 P21728 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
SLC6A3 Q01959 1/20 0.46
HTR6 P50406 3/20 0.45
HTR2B P41595 2/20 0.45
HTR3A P46098 3/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR2C P28335 1/20 0.44
DRD4 P21917 1/20 0.44
HTR5A P47898 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5987905 0.98 KDR (0.49) KDRHTR1ASLC6A2SLC6A4HTR7
SCHEMBL4960481 0.87 ALDH1A1 (0.50) DRD2HTR3ADRD4
SCHEMBL14570983 0.86 KDR (0.50) KDRHTR1ASLC6A2SLC6A4HTR7
SCHEMBL233938 0.81 KDR (0.53) KDRHTR1ASLC6A2SLC6A4HTR7
SCHEMBL29557426 0.81 KDR (0.53) KDRHTR1ASLC6A2SLC6A4HTR7
SCHEMBL30952449 0.80 ADRB1 (0.56) KDRHTR1ASLC6A2SLC6A4HTR7
Hydrochloric Acid SCHEMBL4331979 0.80 KDR (0.51) KDRHTR1ASLC6A2SLC6A4HTR7
SCHEMBL231592 0.80 ADRB1 (0.56) KDRHTR1ASLC6A2SLC6A4HTR7
Hydrochloric Acid SCHEMBL29883289 0.80 KDR (0.51) KDRHTR1ASLC6A2SLC6A4HTR7
Hydrochloric Acid SCHEMBL5987897 0.80 KDR (0.51) KDRHTR1ASLC6A2SLC6A4HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186715-B2 Piperazine- and piperidine-derivatives as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-03-06 US disclosed
CN-1145609-C Piperazine compounds and medical use thereof ������ҩ��ʽ���� 2004-04-14 CN disclosed
CN-1118459-C Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2003-08-20 CN disclosed
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
CN-1281438-A Piperazine compounds and their use as pharmaceuticals EFUKU CO LTD (JP) 2001-01-24 CN disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
CN-1149051-A Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 1997-05-07 CN disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed